Inhibrx - Stock Price History | INBX

Historical daily share price chart and data for Inhibrx since 2022 adjusted for splits. The latest closing stock price for Inhibrx as of May 27, 2022 is 13.65.
  • The all-time high Inhibrx stock closing price was 50.00 on December 17, 2020.
  • The Inhibrx 52-week high stock price is 47.90, which is 250.9% above the current share price.
  • The Inhibrx 52-week low stock price is 11.56, which is 15.3% below the current share price.
  • The average Inhibrx stock price for the last 52 weeks is 29.00.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Inhibrx Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 30.1584 31.2600 46.0200 14.6900 43.6700 32.45%
2020 23.9004 20.6300 50.0000 15.9600 32.9700 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.533B $0.007B
Inhibrx Inc. is a clinical-stage biotechnology company. The company's pipeline is focused on oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $162.107B 9.86
Bio-Rad Laboratories (BIO.B) United States $15.121B 32.79
QIAGEN (QGEN) Netherlands $10.761B 16.99
Biohaven Pharmaceutical Holding (BHVN) United States $10.111B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.648B 0.00
Emergent Biosolutions (EBS) United States $1.770B 7.57
Arcus Biosciences (RCUS) United States $1.376B 34.89
Myovant Sciences (MYOV) United Kingdom $1.033B 0.00
Zymeworks (ZYME) Canada $0.397B 0.00
Gelesis Holdings (GLS) United States $0.345B 0.00
Ambrx Biopharma (AMAM) United States $0.157B 0.00
Enzo Biochem (ENZ) United States $0.110B 22.60
SQZ Biotechnologies (SQZ) United States $0.100B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00